175 related articles for article (PubMed ID: 22537348)
41. Brown tumor of secondary hyperparathyroidism: surgical approach and clinical outcome.
Queiroz IV; Queiroz SP; Medeiros R; Ribeiro RB; Crusoé-Rebello IM; Leão JC
Oral Maxillofac Surg; 2016 Dec; 20(4):435-439. PubMed ID: 27640197
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
43. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia.
Mathur A; Ahn JB; Sutton W; Chu NM; Gross AL; Segev DL; McAdams-DeMarco M
Nephrol Dial Transplant; 2022 Oct; 37(11):2111-2118. PubMed ID: 35512551
[TBL] [Abstract][Full Text] [Related]
44. Surgical management of renal hyperparathyroidism: a preliminary series report.
Diaconescu MR; Glod M; Costea I; Grigorovici M; Covic A; Diaconescu S
Chirurgia (Bucur); 2011; 106(1):51-7. PubMed ID: 21520775
[TBL] [Abstract][Full Text] [Related]
45. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.
Komaba H; Taniguchi M; Wada A; Iseki K; Tsubakihara Y; Fukagawa M
Kidney Int; 2015 Aug; 88(2):350-9. PubMed ID: 25786097
[TBL] [Abstract][Full Text] [Related]
46. An epidemiologic analysis of parathyroidectomy in chronic dialysis patients. The Okinawa Dialysis Study Group.
Tokuyama K; Iseki K; Yoshi S; Yoshihara K; Nishime K; Uehara H; Tozawa M; Wake T; Arakaki M; Fukiyama K
Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):309-13. PubMed ID: 8741393
[TBL] [Abstract][Full Text] [Related]
47. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation.
Drakopoulos S; Koukoulaki M; Apostolou T; Pistolas D; Balaska K; Gavriil S; Hadjiconstantinou V
Am J Surg; 2009 Aug; 198(2):178-83. PubMed ID: 19217601
[TBL] [Abstract][Full Text] [Related]
48. Resurgence of parathyroidectomy: evidence and outcomes.
Komaba H; Nakamura M; Fukagawa M
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):243-249. PubMed ID: 28375871
[TBL] [Abstract][Full Text] [Related]
49. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
[TBL] [Abstract][Full Text] [Related]
50. Significance of minimodeling in dialysis patients with adynamic bone disease.
Ubara Y; Tagami T; Nakanishi S; Sawa N; Hoshino J; Suwabe T; Katori H; Takemoto F; Hara S; Takaichi K
Kidney Int; 2005 Aug; 68(2):833-9. PubMed ID: 16014063
[TBL] [Abstract][Full Text] [Related]
51. Survival following parathyroidectomy among United States dialysis patients.
Kestenbaum B; Andress DL; Schwartz SM; Gillen DL; Seliger SL; Jadav PR; Sherrard DJ; Stehman-Breen C
Kidney Int; 2004 Nov; 66(5):2010-6. PubMed ID: 15496173
[TBL] [Abstract][Full Text] [Related]
52. [Management of renal osteopathy in patients with chronic dialysis].
Kiss D; Brunner FP
Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
[TBL] [Abstract][Full Text] [Related]
53. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients.
Charhon SA; Berland YF; Olmer MJ; Delawari E; Traeger J; Meunier PJ
Kidney Int; 1985 Feb; 27(2):426-35. PubMed ID: 2581010
[TBL] [Abstract][Full Text] [Related]
54. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
[TBL] [Abstract][Full Text] [Related]
55. Cauda equina compression revealing brown tumor of the spine in a long-term hemodialysis patient.
Tarrass F; Ayad A; Benjelloun M; Anabi A; Ramdani B; Benghanem MG; Zaid D
Joint Bone Spine; 2006 Dec; 73(6):748-50. PubMed ID: 16650789
[TBL] [Abstract][Full Text] [Related]
56. Pretransplant parathyroidectomy in renal failure: effects on bone histology and aluminum deposits during dialysis and after kidney transplantation.
Dahl E; Nordal KP; Halse J; Flatmark A
Scand J Urol Nephrol; 1992; 26(3):283-8. PubMed ID: 1439604
[TBL] [Abstract][Full Text] [Related]
57. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
[TBL] [Abstract][Full Text] [Related]
58. Assessment of resource use and costs associated with parathyroidectomy for secondary hyperparathyroidism in end stage renal disease in the UK.
Pockett RD; Cevro E; Chamberlain G; Scott-Coombes D; Baboolal K
J Med Econ; 2014 Mar; 17(3):198-206. PubMed ID: 24279874
[TBL] [Abstract][Full Text] [Related]
59. [Results and complications of parathyroidectomy in secondary hyperparathyroidism].
Berczi C; Nagy A; Mátyus J; Balázs G; Kakuk G; Lukács G
Magy Seb; 2001 Dec; 54(6):356-60. PubMed ID: 11816132
[TBL] [Abstract][Full Text] [Related]
60. Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy.
Yang YL; Lu HF; Chung KC; Jawan B; Chou FF
J Clin Anesth; 2015 May; 27(3):195-200. PubMed ID: 25434503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
